Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA
March 29, 2024
By: Aaron Savit, and Ian Swan*
FDLI’s Update Magazine, Spring 2024 Issue
Axinn associates Aaron Savit and Ian Swan co-authored the article "Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA," published in the Spring 2024 issue of the Food and Drug Law Institute's Update magazine.
Click here to access the article. Shared with the permission of FDLI.
Click here to access the Spring 2024 issue of Update magazine.
*Not yet admitted to the Washington, DC Bar.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Axinn Attorneys Recognized by IAM Patent 1000
News
Intellectual Property
Intellectual Property and Antitrust
Byline Articles
Intellectual Property
Axinn Recognized by Legal 500 2025 U.S. Guide for Excellence in Antitrust and Litigation
Awards & Recognitions
Axinn’s New Office in Rockefeller Center Promises To Be Collaborative Hub Designed To ‘Attract Top Talent’
Media Mentions
Antitrust